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Abstract
Background: Magnetic	resonance	 imaging	 (MRI)	of	the	colonic	response	to	a	mac-
rogol challenge drink can be used to assess the mechanisms underlying severe con-
stipation.	We	measured	the	intrasubject	reproducibility	of	MRI	measures	of	colonic	
function to aid their implementation as a possible clinical test.
Methods: Healthy	participants	attended	for	MRI	on	two	occasions	(identical	proto-
cols,	minimum	1	week	apart).	They	underwent	a	fasted	scan	and	then	consumed	the	
macrogol	drink.	Subjects	were	scanned	at	60	and	120	minutes,	with	maximum	value	
reached	used	for	comparison.	The	colonic	volume,	water	content,	mixing	of	colonic	
content and the movement of the colon walls were measured. Coefficients of varia-
tion	and	intraclass	correlation	coefficients	(ICC)	were	calculated.
Results: Twelve	participants	completed	the	study:	nine	female,	mean	age	26	years	
(SD	5)	and	body	mass	index	24.8	kg/m2	(SD	3.2).	All	measures	consistently	increased	
above	baseline	following	provocation	with	macrogol.	The	volume,	water	content	and	
content	mixing	had	good	intrasubject	reproducibility	(ICC	volume	=	0.84,	water	con-
tent =	0.93,	mixing	=	0.79,	P <	.001).	With	the	wall	movement,	the	response	to	the	
challenge	was	generally	large,	but	more	variable	between	visits	resulting	in	a	lower	
ICC overall (ascending colon =	0.65,	descending	colon	=	0.76,	P <	.001).
Conclusions: The	colonic	response	to	the	macrogol	stimulus	as	assessed	by	MRI	is	
heterogeneous	 but	 large	 compared	 to	 baseline,	with	moderate	 to	 good	 reproduc-
ibility,	making	 the	 test	 suitable	 to	study	potential	pathologies	underlying	GI	disor-
ders	such	as	constipation.	More	data	are	needed	to	better	define	the	normal	range	
for	 comparison	 with	 patient	 groups	 who	 may	 have	 both	 hypo-	 and	 hypermotile	
responses.
K E Y W O R D S
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1  | INTRODUC TION
Constipation	is	a	common	condition,	affecting	on	average	14%	of	the	
world population.1	For	those	affected,	it	can	have	a	serious	impact	
on	quality	of	life2 and associated economic cost.3
The	 latest	 Rome	 Criteria	 (Rome	 IV)	 split	 primary	 constipation	
into	functional	constipation	(FC)	and	irritable	bowel	syndrome	with	
constipation	 (IBS-C),	 distinguished	 by	 the	 presence	 or	 absence	 of	
pain in association with bowel habit. These conditions may have dif-
ferent	underlying	mechanisms,	requiring	quite	different	treatments.	
Distinguishing these conditions in the clinic based mostly on patient 
report	 leads	 to	 trial	 and	 error	 treatments	which	may	 explain	why	
nearly	50%	of	patients	are	dissatisfied	with	their	treatment.4
A	novel	diagnostic	 test	using	magnetic	 resonance	 imaging	 (MRI)	
based on the consumption of a macrogol challenge drink has been 
developed to define the underlying mechanisms of severe constipa-
tion.5,6	This	looked	at	assessment	of	the	colonic	volumes,	water	con-
tent	and	mixing	of	colonic	chyme,	as	well	as	movements	of	the	colon	
walls,	critical	components	in	defining	organ	function.	This	showed	that	
there	may	be	distinct	differences	between	the	two	groups	of	patients,	
and	if	this	is	the	case,	then	they	would	likely	need	different	treatments.
It is currently unknown how reproducible the response of the 
colon	 is	 to	 this	 stimulus	 test.	 Previous	 studies	 have	 looked	 at	 the	
variability	and	reproducibility	of	other	GI	measurements	such	as	gas-
tric	emptying	and	transit,	as	well	as	manometry	techniques	and	have	
found	considerable	inter-	and	intrasubject	variability	using	a	variety	
of	analytical	methods	 including	coefficients	of	variation,	 intraclass	
correlation	coefficients	(ICC)	and	Bland-Altman	analysis.7-11
The main aim of this study was to measure the intrasubject reproduc-
ibility	of	these	MRI	colon	function	measures	using	an	open-label	study	
design	in	a	group	of	healthy	volunteers.	A	secondary	aim	was	to	assess	
the feasibility of measuring the motor function of the descending colon 
(not	studied	in	previous	work)	since	abnormalities	of	distal	colon	function	
are also likely to be an important determinants of bowel function.
2  | METHODS
2.1 | Study design
This	was	an	open-label	study	examining	the	reproducibility	of	the	re-
sponse	of	the	large	intestine	to	acute	ingestion	of	500	to	1000	mL	of	
Key Points
•	 A	novel	diagnostic	test	using	MRI	and	a	macrogol	chal-
lenge drink can objectively assess colonic physiology 
(volume,	 fluid	 flow,	 wall	 motility,	 and	 water	 content).	
However,	the	reproducibility	of	these	responses	has	not	
been investigated.
• This study assessed the intrasubject reproducibility of 
these colonic responses in healthy volunteers using 
identical study protocols on two separate occasions.
•	 Colonic	water	 content,	 volumes,	 fluid	 flow,	 and	motil-
ity all consistently increased above baseline values 
post	stimulus.	The	colonic	water,	volume,	and	flow	data	
had	good	 intrasubject	 reproducibility.	AC	and	DC	mo-
tility were reasonably repeatable at baseline but the 
response to the challenge was variable between visits 
resulting in a lower ICC. This makes it a suitable test 
to	 study	potential	 pathologies	underlying	GI	disorders	
such as constipation.
F I G U R E  1  Schematic	of	the	study	day
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poly-ethylene	glycol	 and	electrolyte	 solution	 (Moviprep®,	Norgine	
Pharmaceuticals	Ltd).
The	 study	 was	 approved	 by	 the	 Ethics	 Committee	 of	 the	
University	 of	 Nottingham	 (Nottingham,	 UK)	 [UoN	 FMHS	
D10052016	SPMIC	MR].	The	study	was	carried	out	according	to	
Good	Clinical	Practice	principles,	and	all	participants	gave	written	
informed consent.
2.2 | Subjects
Twelve healthy volunteers were recruited from the general campus 
population	at	the	University	of	Nottingham	by	advertisement.	The	
inclusion	criteria	were	male	or	female,	18-55	years	of	age	and	body	
mass	 index	between	18	and	30	kg/m2.	The	exclusion	criteria	were	
pregnancy,	any	history	of	serious	acute	or	chronic	illness	especially	
gastrointestinal,	use	of	medication	known	to	affect	gastrointestinal	
transit,	such	as	opiates	and	constipating	drugs,	substance	abuse	and	
unsuitability	 for	MRI	 scanning	 (such	 as	 pacemaker).	 Prior	 to	 each	
study	 visit,	 participants	were	 asked	 to	 complete	 the	 Talley	 bowel	
habit	questionnaire12 and screening diary to ensure they did not suf-
fer	from	recurrent	abdominal	pain	and	bowel	frequency	was	normal	
(defined as bowel movements >2 and <10 over the 3 days prior to 
each	MRI	study	day).
2.3 | Study day protocol
Each	participant	attended	the	study	centre	on	two	occasions,	at	
least	1	week	apart.	They	were	asked	to	avoid	strenuous	exercise,	
dietary supplements and alcohol for 24 hours prior to the study 
visit	and	caffeine	for	18	hours.	On	the	morning	of	the	scan,	partici-
pants arrived fasted (from 10.30 pm	the	night	before)	at	the	study	
centre.
After	 completing	 the	 daily	 eligibility	 questionnaire,	 partici-
pants	underwent	a	20	-	30	minute	MRI	baseline	scanning	session.	
Participants	 then	 drank	 10	 mL/kg	 of	 body	 weight	 (rounded	 to	
100	mL)	of	Moviprep®,	at	a	rate	of	2.5	mL/kg	per	15	minutes.	This	
was	based	on	previous	experience	 that	using	 fixed	doses	of	1000	
or	2000	mL	made	smaller	 subjects	unduly	nauseated	so	 that	 they	
could not reliably consume the prescribed amounts introducing an 
uncontrolled	source	of	variation	between	subjects.	Participants	un-
derwent	two	further	20	-	30	minute	scan	sessions	at	60	(T60)	and	
120	(T120)	minutes	after	starting	the	macrogol	drink	(see	schematic	
Figure	1).
Participants	were	asked	to	rate	their	symptoms	of	pain,	bloating	
and flatulence as absent =	0,	mild	=	1,	moderate	= 2 and severe = 3 
using	 the	 questionnaire	 of	 Tornblom13	 at	 baseline,	 immediately	
after	finishing	the	drink	(T60)	and	60	minutes	later	(T120,	Figure	1).	
Participants	were	also	asked	to	record	the	time	of	their	first	bowel	
movement	following	the	drink	(TBM).
F I G U R E  2  A	+	B,	Pre-	and	post-stimulus	anatomical	3D	
rendered images for analysis of colonic volume. C +	D,	Pre-	and	
post-stimulus	tagging	images	(content	mixing)	of	the	AC,	in	Figure	C	
the	tagging	lines	remain	horizontal,	whereas	in	D,	they	are	distorted	
by	fluid	flow	in	the	AC	(arrow).	E	+	F,	Images	from	wall	movement	
analysis,	vertical	lines	are	drawn	at	the	edge	of	the	descending	
colon	which	move	with	contractions	(arrow).	G	+	H,	Pre-	and	
post-stimulus	STMM	Maps	produced	from	wall	movement	analysis,	
showing meal response
(A) (B)
(C) (D)
(E) (F)
(G) (H)
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2.4 | MRI protocol
Imaging	was	carried	out	on	a	3.0T	Ingenia	wide-bore	scanner	(Philips,	
Best,	 The	 Netherlands)	 with	 a	 parallel	 imaging	 SENSE	 abdominal	
body	receiver	coil.	A	 range	of	MRI	sequences	were	used	to	 image	
the abdomen including:
1.	 Colonic	 regional	 and	 total	 volumes:	 a	 3D	 coronal	 dual-echo	
fast	 field	 echo	 sequence	 with	 mDIXON	 reconstruction.14
2.	 Bowel	Water	Content:	A	single	shot,	 coronal	 fast	 spin	echo	se-
quence	(rapid	acquisition	with	relaxation	enhancement,	RARE).
3.	 MRI	content	mixing	measurement:	A	single	10	mm	slice	cine	bTFE	
with tag lines 12 mm apart.
4.	 MRI	 wall	 movement	 measurement:	 Cine	 bTFE	 (balanced	 turbo	
field	echo).
Full	 sequence	 information	 is	 detailed	 in	 Table	 S4.	 Data	 were	
acquired	 on	 an	 expiration	 breath-hold	 with	 duration	 between	 18	
and	24	seconds	depending	on	the	sequence	(for	the	first	three	se-
quences)	 and	 monitored	 using	 a	 respiratory	 belt.	 The	 colon	 wall	
measurement	 sequence	was	 duration	10	minutes	with	 a	 temporal	
resolution	of	1	s	acquired	during	gentle	free	breathing.
TA B L E  1  Summary	data	of	all	MRI	endpoints	measured
Measurement Time point Visit 1 Visit 2
CoV CoV Intraclass correlation coefficient (ICC)
(Intrasubject) (Intersubject)
(Baseline and Maximum, Visit 1 vs 
Visit 2)
% % Lower Upper
Colon volume 
(mL)† 
Baseline 728	±	267 768	±	246 14 34 0.84 0.67 0.93 <0.001
Maximum 1226	±	336 1199 ± 242 11 24
(Base-max)a  P < .0001 P < .0001
Total water 
content	(mL)† 
Baseline 113 ±	63.3 108	± 49 34 51 0.93 0.84 0.97 <0.001
Maximum 1071	±	266 1060	± 313 18 27
(Base-max)a  P < .0001 P < .0001
Colonic water 
content	(mL)
Baseline 0	(0) 0	(0) * * 0.85 0.7 0.93 <0.001
Maximum 538	±	278 540 ± 242 29 48
(Base-Max)b  P = .0005 P = .0005
Content	mixing	
AC	(%)
Baseline 18	±	8 16	±	6 14 41 0.76 0.49 0.89 <0.001
Maximum 35 ± 10 30 ±	7 13 27
(Base-max)a  P < .0001 P < .0001
Content	mixing	
DC	(%)
Baseline 23 ±	8 22 ±	7 15 33 0.62 0.3 0.81 <0.001
Maximum 31 ± 11 28	±	7 16 29
(Base-max)a  P =	.0106 P =	.0177
Wall	movement	
AC	(a.u)
Baseline 272	(37-710) 135	(37-264) 85 94 0.65 0.35 0.83 <0.001
Maximum 1886	
(955-3669)
1877	
(1613-2163)
32 70
(Base-Max)b  P = .0015 P = .0005
Wall	movement	
DC	(a.u)
Baseline 258	
(104-460)
441 
(167-911)
64 76 0.76 0.53 0.89 <0.001
Maximum 2249 
(1786-2834)
1941	(1454-
3864)
32 53
(Base-Max)b  P = .0005 P = .0005
Time	to	Bowel	
Movement	
(min)
95	(95-113) 90	(51-133) 110 19 0.98 0.94 0.99 <0.001
Note: Data presented as either mean ±	SD	or	median	(interquartile	range).	All	individual	time	point	post-stimulus	data	in	Table	S3.
Abbreviations:	AC,	ascending	colon;	DC,	descending	colon.
aPaired	t test. 
bPaired	Wilcoxon.	
*CoV unable to be calculated due to the large number of zero data. 
†Further	segmented	data	in	Tables	S1	and	S2.	
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2.5 | Image analysis
Analyses	 were	 performed	 with	 automated	 and	 semi-automated	
image	analysis	software,	Analyze9®	(Mayo	Clinic)	and	software	writ-
ten	using	Matlab®	(The	MathWorks	Inc)	and	IDL®	(Research	Systems	
Inc).	Colonic	volumes	and	water	content	(mL)	were	measured	as	pre-
viously described.15-17	For	the	colonic	volume	data,	the	slice	thick-
ness was increased to 5.4 mm by averaging three consecutive slices 
to reduce the number of images to be used in the analysis from 111 to 
37.	Colonic	content	mixing	within	the	colon	was	assessed	using	the	
average	coefficient	of	variance	(%)	for	the	colonic	region	of	interest	
in	the	tagged	cine	MRI	data.17 This was calculated from mean and 
standard	deviation	maps	of	the	voxel	intensities	measured	across	the	
time	series	cine	data,	with	a	user-defined	region	of	 interest	drawn	
round the colon contents on the mean intensity map.
For	 the	 colonic	wall	movements,	 the	untagged	 cine	data	were	
non-linearly	 registered	 across	 the	 time	 course	 using	 GIQuant® 
(Motilient	 Ltd).18	 The	 spatio-temporal	 motility	 technique	 (STMM)	
was then used to assess changes in luminal diameter with time 
(due	to	contractions)	along	the	AC	and	DC	using	software	written	
in	Matlab,19,20 and these data were used to calculate the combined 
velocity	distance	motility	index	(a.u.).20	Briefly,	the	speed	of	the	wall	
F I G U R E  3  Bland-Altman	plots	showing	difference	vs	average	with	dotted	lines	representing	bias	and	95%	limits	of	agreement,	and	a	
paired t	test	or	Wilcoxon	test	(if	non-normal	data)	used	to	assess	for	significance	of	this	bias
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F I G U R E  4  Correlation	all	endpoints	at	baseline	and	maximum,	with	line	of	identity	shown,	visit	1	vs	visit	2
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motion was multiplied with the normalized luminal diameter changes 
to	 generate	 a	 plot	 highlighting	 both	 deformation	 (expansion	 and	
contraction)	and	motion	of	the	bowel	wall.	The	area	under	this	plot	
above	a	threshold	value	(which	excluded	breathing	noise	artifacts	in	
the	data)	was	then	calculated.
2.6 | Statistical analysis
Basic	 characteristics	 of	 the	 study	 population	 were	 summarized	
using	 frequencies,	 percentages,	means	 and	 standard	deviations	 as	
appropriate.	The	maximum	value	after	 the	drink	 for	each	MRI	pa-
rameter	was	determined	from	T60	and	T120	data	for	each	subject	
to	allow	 for	 the	 fact	 that	oro-cecal	 transit	 times	of	 the	drink,	 and	
hence	 time	 of	 peak	 colonic	 distension,	 could	 differ	 between	 the	
two	visits.	Normality	of	data	was	assessed	using	the	D’Agostino	and	
Pearson	normality	test,	and	all	statistical	tests	were	performed	using	
GraphPad	Prism	version	7.03	for	Windows	(GraphPad	Software).
The	 reproducibility	 of	 these	 MRI	 parameters	 (volumes,	 water	
content,	content	mixing	and	wall	movement)	as	well	as	time	to	first	
bowel	 movement	 (TBM)	 was	 determined	 by	 carrying	 out	 Bland-
Altman	 analysis.21	 Coefficients	 of	 variation	 ((Standard	 Deviation/
Mean)	×	100)	 for	 intrasubject	data	and	 ICC	 (using	 two	way	mixed	
models	with	absolute	agreement)	were	calculated	 for	 the	baseline	
and	maximum	values	acquired	by	T = 120 minutes from starting the 
drink,	analyzed	from	the	two	visits.	Intersubject	coefficient	of	vari-
ance data was also assessed to determine whether the intrasubject 
variability was similar to the intersubject variability.
Bland-Altman	plots	were	generated	with	dotted	lines	represent-
ing	bias	and	95%	limits	of	agreement,	and	a	paired	t	test	or	Wilcoxon	
test	 (if	 non-normal	data)	was	used	 to	 assess	 the	 statistical	 signifi-
cance	of	this	bias.	For	ICC,	the	95%	confidence	interval	of	the	ICC	
estimate is used as the basis to evaluate the level of reliability using 
the following general guideline:
Values	less	than	0.5	are	indicative	of	poor	reliability,	
values	 between	 0.5	 and	 0.75	 indicate	moderate	 re-
liability,	 values	 between	 0.75	 and	 0.9	 indicate	 good	
reliability,	and	values	greater	than	0.90	indicate	excel-
lent reliability.22
We	also	looked	at	the	use	of	a	“responder	rate”	to	assess	the	wall	
movements	response	to	the	stimulus,	using	the	90%	centile	of	baseline	
values	as	a	cut	off	for	a	definition	of	“responder”;	we	determined	whether	
participants responded to the macrogol stimulus the same way on both 
occasions. This follows the assumption that the baseline data represent 
the no or very low motility state with its inherent measurement error due 
to breathing and positioning of the lines to generate the motility metric. 
A	90%	limit	to	this	baseline	data	would	therefore	give	a	realistic	upper	
limit to the no motility state. Response to stimulus was also tested in all 
MRI	endpoints	at	both	visits	using	either	the	paired	t	test	or	Wilcoxon	
test	of	baseline	and	maximum	values,	to	determine	whether	a	significant	
increase in each endpoint was measured after the macrogol drink.
This was a pilot study to enable us to make power calculations 
for	the	MRI	endpoints	for	future	studies.	Given	the	expense	of	these	
studies,	we	chose	a	sample	size	of	12	which	we	felt	was	a	reasonable	
compromise and has some justification based on rationale around 
feasibility and precision of estimates.23	A	previous	manometry	 re-
producibility study showed good reproducibility in ambulatory ma-
nometry readings with just seven participants.9
3  | RESULTS
Twelve	participants	were	recruited:	nine	female,	 three	male,	mean	
age	26	(SD	5)	and	body	mass	index	24.8	(SD	3.2)	kg/m.	Examples	of	
images	obtained	for	analysis	are	shown	in	Figure	2,	highlighting	the	
features	extracted	from	the	MRI	data.
3.1 | Reproducibility measures
The	details	of	the	summary	data	for	our	MRI	endpoints	and	TBM	as	
well	as	coefficients	of	variation	and	ICC	are	shown	in	Table	1.	All	MRI	
endpoints	 changed	 significantly	 from	baseline	 to	maximum	values	
following	the	macrogol	challenge	(Table	1).
F I G U R E  5  Graph	of	responders/non-responders	for	colonic	wall	movement
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For	all	endpoints,	the	intrasubject	CoV	was	smaller	than	the	inter-
subject	CoV.	The	ICCs	were	more	varied	with	all	the	ICC’s	above	0.6	
(moderate);	however,	some	of	the	lower	limits	of	the	95%	CI	dropped	
to 0.3. The ICC for volumes and water content performed best with 
colonic	volume	ICC	at	0.84,	and	maximum	total	gut	water	content	and	
maximum	 colonic	 water	 content	 were	 0.92	 and	 0.85,	 respectively.	
Reproducibility	for	mixing	and	movement	measurements	of	both	the	
contents	and	walls	in	both	the	AC	and	DC	performed	less	well	(ranged	
from	0.62	to	0.76).	The	time	to	bowel	movement	had	an	ICC	of	0.98.
Bland-Altman	 plots	 are	 shown	 in	 Figure	 3	 for	 the	 maximum	
post-stimulus	 data	 only,	 which	 show	 no	 statistically	 significant	 bias	
in	 the	 data;	 however,	 the	 95%	 limits	 of	 agreement	 varied	 greatly.	
Correlation	graphs	of	baseline	and	maximum	values,	with	line	of	iden-
tity	shown,	visit	1	vs	visit	2,	are	shown	in	Figure	4	and	show	the	large	
effect	of	the	macrogol	stimulus	on	the	MRI	endpoints	measured.
3.2 | Responder rate
Using	the	90%	centile	of	baseline	values	as	a	cutoff	for	a	definition	of	
“responder”	to	the	stimulus,	the	results	of	the	individual	peak	values	
with	a	responder	line	for	both	AC	and	DC	wall	movement	are	shown	
in	Figure	5.	This	 shows	 that	 for	 the	AC,	 all	 participants	kept	 their	
responder status and in the DC one participant changed responder 
status across visits.
3.3 | Symptom scores
Symptom	 scores	 for	 abdominal	 pain,	 flatulence	 and	 bloating	were	
all	 low.	 All	 participants	 scored	 zero	 at	 baseline	 for	 all	 symptoms.	
For	 both	 visits	 at	 T60	 and	 T120,	median	 scores	were	 all	<0.5 for 
all symptoms. There was no significant difference found between 
visit 1 and 2 scores for any symptoms at both time points (p values 
between P = .44 and P >	.9,	Wilcoxon	test).
4  | DISCUSSION
Our	results	 indicate	that	colonic	volumes,	content	mixing	and	wall	
movement	all	 consistently	 increased	above	baseline	post-stimulus.	
This is consistent with previously published data on healthy volun-
teers	using	different	quantities	of	the	macrogol	challenge	drink.5,6,17 
MRI	endpoints	showed	large	intersubject	variability	with	coefficients	
of	variation	across	the	cohort	ranging	from	33%	to	94%.	Importantly,	
the intrasubject variability was lower than the intersubject variabil-
ity	for	all	endpoints	measured	(range	11%-85%).	This	means	that	all	
individuals’	data	had	more	in	common	with	itself	than	with	the	group	
as a whole.
The	colonic	volume	and	AC	content	mixing	data	had	good	intra-
subject	 reproducibility.	Fasting	colonic	volumes	have	already	been	
shown to be consistent on different occasions24,25;	 however,	 the	
fact	that	these	volume	and	content	mixing	measurements	were	also	
reproducible	 post-stimulus	 suggests	 that	 these	 responses	 are	 rel-
atively	 consistent	 and	 change	 quite	 slowly	 over	 the	measurement	
time.	This	is	particularly	the	case	for	the	AC	content	mixing	measure-
ment,	a	dynamic	flow	measurement,	also	known	as	tagging,	which	
is	effectively	acquired	for	 just	40	seconds	 (20-seconds	acquisition	
with	a	gap	of	1	hour).	If	this	content	mixing	was	more	erratic,	a	bigger	
variation	in	the	data	would	be	observed.	In	addition	to	this,	by	allow-
ing	a	maximum	value	of	the	response	to	be	used	in	this	protocol,	it	
has	removed	some	of	the	variation	that	changes	in	oro-cecal	transit	
time	between	visits	could	introduce,	which	would	in	turn	impact	on	
the response of the colon to the stimulus.
AC	and	DC	wall	movement	were	reasonably	repeatable	at	base-
line,	with	a	low	metric	measured	compared	to	the	post-stimulus	data,	
but the response to the challenge was variable between study days 
resulting in a lower ICC overall and indicating variability in the physi-
ological	response	to	the	stimulus,	likely	due	to	the	irregular	nature	of	
colonic contractions following the macrogol drink. It is known from 
manometry	data	that	 in	resting	condition,	colonic	contractions	are	
erratic; a study in healthy volunteers performed over 4 hours found 
that	high	amplitude	contractions	make	up	only	1.4%	of	the	contrac-
tile activity of the colon.26	Simultaneous	detection	of	these	high	am-
plitude	contractions	from	manometry	with	MRI	has	been	previously	
shown	 by	Kirchhoff	 et	 al27 who also showed low motility in their 
basal data prior to bisacodyl instillation in the DC. They also showed 
that	following	the	bisacodyl	not	all	subjects’	colons	produced	high	
amplitude	contractions	during	their	24-minute	measurement	period,	
with some subjects producing multiple contractions and others none 
at	all.	Given	 the	 fact	 that	 the	wall	movement	 scanning	acquisition	
time	was	 just	10	minutes	each	scan	session,	 it	perhaps	 is	not	 that	
surprising that larger variability was found for these data using this 
method.	 The	 contractions	 seen	 in	 the	wall	 of	 the	AC	 and	DC	 fol-
lowing	the	macrogol	drink	are	not	continuous,	but	sporadic	and	will	
depend on several factors. These would include the rate of delivery 
of	the	macrogol	to	the	AC,	mixing	of	the	macrogol	with	the	colonic	
contents	already	present,	and	the	absorption	rate	of	any	fluid	from	
the	macrogol.	All	 these	factors	will	 influence	the	distension	of	the	
colon wall which is probably the main trigger for the wall motion ob-
served. The water content measurements showed there was larger 
variability	of	this	measure,	across	the	two	visits,	compared	to	the	co-
lonic volumes (although individual colonic segments showed larger 
variation	 [Table	 S1])	 and	 colonic	 content	mixing,	 again	 supporting	
the	assumption	of	variable	oro-cecal	transit	of	the	macrogol	to	the	
colon	and	its	subsequent	transport	and	absorption.
However,	 with	 our	 definition	 of	 responder	 (ie,	 those	 whose	
post-stimulus	response	was	greater	than	the	90%	centile	of	baseline	
values	defining	 the	 “no	motility”	 state),	 all	 subjects	kept	 the	 same	
status	for	AC	wall	movements	and	only	one	changed	for	DC	across	
visits.	The	DC	definition	of	responder	was	set	higher	than	the	AC	due	
to larger amounts of movement present during the baseline scan for 
this region of the colon. There is also more susceptibility of the DC to 
artifacts from the motion in the neighboring small bowel which may 
erroneously	increase	the	index.	Since	intra-	and	inter-individual	vari-
ability	in	baseline	motility	were	very	similar,	we	felt	it	reasonable	to	
use	a	single	threshold	of	90%	of	group	values	rather	than	expressing	
response	as	a	fixed	%	change	from	individual	baseline.	This	approach	
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is likely to be used in clinical practice when looking for abnormalities 
in motility in patient populations.
The time to first bowel movement also showed low variability 
across	the	visits;	however,	it	is	worth	noting	that	due	to	the	nature	of	
the	study	days	patients	were	more	likely	to	go	in	the	half-hour	peri-
ods	they	had	between	scans,	and	no	participants	needed	to	go	while	
in the scanner itself (or at least did not ask to be taken out the scan-
ner	mid	scan)	which	constrains	the	data	to	 limited	values	and	may	
artificially improve its reproducibility. This parameter has obvious 
face	validity	and	is	highly	relevant	to	patient	management;	however,	
although	a	useful	objective	clinical	measure,	it	does	not	define	the	
abnormality	of	colonic	function.	Being	a	large	stimulus,	it	overcomes	
the uncontrolled variability in baseline values to yield a value which 
is highly reproducible compared to baseline parameters. It could 
be useful as a screening test to determine who would benefit from 
the	more	expensive	and	detailed	MRI	test.	While	our	procedures	at	
present	may	be	too	demanding	for	routine	clinical	use,	we	believe	a	
single scan assessing colonic volume and colonic wall movement at 
60	minutes	could	provide	a	cost-effective	way	of	excluding	colonic	
inertia but this would need testing in a future study that evaluated 
the impact of our test as part of a care pathway.
This	study	was	limited	by	the	relatively	small	sample	size,	espe-
cially	as	 the	data	are	so	heterogeneous,	and	other	 factors	such	as	
diet	in	the	preceding	days	were	not	controlled,	and	this	could	have	
had an impact on the baseline state of the bowel resulting in larger 
variability.	 Equally	 the	 data	 were	 only	 collected	 over	 a	 relatively	
short period (within either breath holds or over 10 minutes for the 
wall	movements),	and	it	 is	possible	that	these	time	periods	are	not	
representative	of	 the	overall	 effect.	 In	 comparison,	 data	 collected	
from	 the	 traditional	manometry	 techniques	 can	 record	 from	2-	 to	
4-hour	up	to	a	24-hour	period;	however,	this	is	impractical	for	MRI	
studies.	Non-dietary	standardization	of	the	baseline	condition	was	
carried	 out	 (only	 fasting	 and	 restricting	 exercise,	 alcohol	 and	 caf-
feine	consumption)	due	to	impracticalities	of	undertaking	a	dietary	
approach in clinical practice. Variable transit times of constipation 
patients would mean that dietary interventions prior to the scan day 
may	influence	some	patients	more	than	others.	In	addition,	request-
ing defecation prior to starting the scanning would be of limited 
use as almost all of the constipation patients would not be able to 
comply.	Some	of	the	variability	seen	in	the	measurements	may	have	
come	from	intra-observer	variability	in	the	analyses	of	the	data.	This	
source of variation in the measurements was beyond the scope of 
the	study.	Previous	limits	of	agreement	data	for	water	content	mea-
surements	have	been	measured	at	−11%	to	13%	(interobserver)	and	
−4%	to	3%	(intra-observer),16	and	for	total	colonic	volumes,	interob-
server	variation	is	around	5%	(unpublished	data).	However,	intra-ob-
server and interobserver variations will be an important determinant 
for	the	use	of	the	individual	MRI	parameters	in	future	studies	and	as	
a clinical test and will be investigated in future studies. The dose of 
macrogol drink was adjusted to subject weight because of our prior 
experience	 that	smaller	people	could	not	 tolerate	 the	 full	1	L.	We	
felt that habitual intake would be proportional to weight rather than 
height,	and	hence,	tolerance	also	affected	by	weight.	In	any	event,	
the doses chosen were well tolerated with median abdominal pain 
and bloating <0.5	on	our	0-3	scale,	but	acknowledge	this	approach	
may have led to some variability in the colonic stimulus.
In	conclusion,	the	colonic	response	to	the	macrogol	challenge	as	
assessed	by	MRI	 is	heterogeneous	but	 large	compared	to	baseline	
data	and	has	moderate	to	good	reproducibility,	making	it	a	suitable	
test	to	study	potential	pathologies	underlying	GI	disorders	such	as	
constipation.	 More	 data	 are	 needed	 to	 better	 define	 the	 normal	
range	for	comparison	with	patient	groups	who	may	have	both	hypo-	
and	hypermotile	responses	to	the	challenge	drink,	and	the	reproduc-
ibility of the test in patients will also need investigating.
We	anticipate	 that	 this	 test	 could	 be	 of	 value	 by	 providing	 an	
objective measure of responsiveness of the colon to the macrogol 
stimulus. It may be particularly valuable in showing that the colon is 
not inert in patients who are dissatisfied with their response to stan-
dard therapies. This would be of value in the work up of patients in 
whom colectomy is being considered and encourage a more vigorous 
search for behavioral abnormalities like pelvic dyssynergia or eating 
disorders which can be missed in routine care.
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